生物标志物 生物标志物
Vincent Malotaux1,2, David Fernando Aguillón Niño3, Isabela Gonzalez1
1Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
概括
通过改变大脑结构,APOE3-Christchurch 变异可能会预防阿尔茨海默病. 异合体载体在额头和顶部区域的皮质厚度增加,可能增强认知储备并延迟疾病发作.
科学领域:
- 神经成像是一种神经成像.
- 遗传学 遗传学 是一个
- 阿尔茨海默氏症疾病研究研究
背景情况:
- APOE3-Christchurch (APOE3Ch) 变种与对阿尔茨海默病 (AD) 的保护有关.
- 了解AD抗性的机制对于开发有效的干预措施至关重要.
- 结构神经成像可以揭示与AD抗性相关的早期大脑变化.
研究的目的:
- 与非载体相比,研究中年异合体APOE3Ch载体中早期结构性大脑差异.
- 分析皮层厚度 (CT) 模式与AD风险和保护因素相关.
主要方法:
- 结构性MRI扫描来自52名非痴呆症患者 (15名APOE3Ch携带者,37名非携带者).
- 基于voxel的形态测量和FreeSurfer分析被用来评估68个感兴趣区域的皮质厚度.
- 收集了临床措施,包括迷你心理状态考试 (MMSE) 和功能评估分期工具 (FAST) 的分数.
主要成果:
- 携带APOE3Ch的携带者表现出前额和顶部区域CT的增加,以及尾部和部区域CT的减少.
- 运营商和非运营商之间没有观察到MMSE或FAST得分的显著差异.
- 与AD相关的感兴趣元区域的皮层厚度在两组之间是可比的.
结论:
- 异合体的APOE3Ch载体表现出明显的早期皮质厚度模式,在前侧-双侧区域的厚度更大.
- 这些前侧-双侧变化可能有助于增强认知储备,可能延迟AD发病.
- 在APOE3Ch载体中的结构性大脑差异可能是他们观察到的对阿尔茨海默病的抵抗力的基础.
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516


